ArticleJournal of translational medicine2009

Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.

Chiung-Ling Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.